Kidney biomarker study for lupus patients
Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study aims to find better ways to detect kidney problems in people with lupus by testing blood and urine samples. If you have lupus, you may help researchers improve how kidney disease is diagnosed and monitored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with systemic lupus erythematosus (SLE, commonly called lupus)
- You receive your routine care at Oslo University Hospital or one of its partner centers
- You are willing to provide blood and/or urine samples for research
- For the kidney biopsy part: you have signs in your blood or urine that suggest possible kidney involvement and you are able to have a kidney biopsy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and urine markers that may show how active lupus kidney disease is and how it changes over time. It may help doctors better monitor people with active lupus-related kidney inflammation.
This study is looking for biomarkers (clues in your blood, urine, or tissue) that can help predict how well lupus nephritis (kidney inflammation caused by lupus) responds to treatment. It focuses on people who have active kidney disease and are either starting treatment or have been on a stable treatment for at least a month.
This study looks at whether simple blood tests can help doctors better understand and track kidney problems that occur in people with lupus. The goal is to see if these markers can predict how the disease will progress, which could help guide treatment.
This study tests whether lupus patients can use a home urine test to monitor their kidney health, which could help catch kidney problems early. It is for patients who have lupus and may have had kidney involvement before, or are at risk of developing it.
This study looks at whether a blood test for a specific antibody can help doctors understand how active lupus kidney disease is. It may help guide treatment decisions for people with lupus nephritis.
This study aims to see if a blood test that measures a specific protein-related molecule can help doctors know how active your lupus is. If successful, this could lead to a simpler way to monitor the disease and adjust treatment.
Hear when a new Lupus Nephritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.